# FIRAZYR General Drug Use-Results Survey (Japan)

> **NCT04057131** · — · COMPLETED · sponsor: **Shire** · enrollment: 179 (actual)

## Conditions studied

- Hereditary Angioedema (HAE)

## Interventions

- **DRUG:** Firazyr

## Key facts

- **NCT ID:** NCT04057131
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-20
- **Primary completion:** 2024-07-29
- **Final completion:** 2024-07-29
- **Target enrollment:** 179 (ACTUAL)
- **Last updated:** 2025-02-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04057131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04057131, "FIRAZYR General Drug Use-Results Survey (Japan)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04057131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*